Karen Murray

1.4k total citations
20 papers, 971 citations indexed

About

Karen Murray is a scholar working on Oncology, Molecular Biology and Geriatrics and Gerontology. According to data from OpenAlex, Karen Murray has authored 20 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 3 papers in Geriatrics and Gerontology. Recurrent topics in Karen Murray's work include Cancer-related Molecular Pathways (6 papers), Sirtuins and Resveratrol in Medicine (3 papers) and Click Chemistry and Applications (2 papers). Karen Murray is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Sirtuins and Resveratrol in Medicine (3 papers) and Click Chemistry and Applications (2 papers). Karen Murray collaborates with scholars based in United Kingdom, United States and Czechia. Karen Murray's co-authors include Virginia Appleyard, Alastair M. Thompson, Julie A. Woods, David P. Lane, Nicholas J. Westwood, Sonia Laı́n, Oliver Staples, Lee D. Baker, Johanna Campbell and Maureen Higgins and has published in prestigious journals such as Cancer Cell, Cancer Research and Scientific Reports.

In The Last Decade

Karen Murray

20 papers receiving 951 citations

Peers

Countries citing papers authored by Karen Murray

Since Specialization

Citations

This map shows the geographic impact of Karen Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Murray more than expected).

Fields of papers citing papers by Karen Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Murray. The network helps show where Karen Murray may publish in the future.

Co-authorship network of co-authors of Karen Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Murray. A scholar is included among the top collaborators of Karen Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Murray. Karen Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness of electronic medical record-based strategies for death and hospital admission endpoint capture in pragmatic clinical trials 2024 ·Journal of the American Medical Informatics Association ·(unknown), (unknown), J. Gopal, Junling Ren, Nathan W. Chan, (unknown), Akshay S. Desai, (unknown), Karen Murray, Thomas C. Havighurst, Jacob A. Udell, Michael E. Farkouh, Lawton S. Cooper, J. Michael Gaziano, Orly Vardeny, Lu Mao, KyungMann Kim, David Gagnon, Scott Solomon, Jacob Joseph	1
2	∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem‐like cells in human ER⁺ and HER2⁺ breast cancers 2019 ·The Journal of Pathology Clinical Research ·Yajing Liu, Marta Nekulová, Rudolf Nenutil, (unknown), M. Virginia C. L. Appleyard, Karen Murray, Jitka Holčáková, (unknown), Philip Quinlan, Lee B. Jordan, Colin A. Purdie, Bořivoj Vojtěšek, Alastair M. Thompson, Philip J. Coates	15
3	In vivo investigation of escitalopram's allosteric site on the serotonin transporter 2015 ·Pharmacology Biochemistry and Behavior ·Karen Murray, Kerry J. Ressler, Michael J. Owens	5
4	Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status 2014 ·The Journal of Pathology ·Pavla Bouchalová, Rudolf Nenutil, Petr Müller, Roman Hrstka, M. Virginia C. L. Appleyard, Karen Murray, Lee B. Jordan, Colin A. Purdie, Philip Quinlan, Alastair M. Thompson, Bořivoj Vojtěšek, Philip J. Coates	20
5	Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6 2013 ·Scientific Reports ·Stephanie F. MacCallum, Michael J. Groves, John James, Karen Murray, Virginia Appleyard, Alan R. Prescott, (unknown), Anna Nicolaou, Joan Cunningham, (unknown), Ian G. Ganley, Nicholas J. Westwood, Philip J. Coates, Sonia Laı́n, Sudhir Tauro	29
6	In vivo dialysis setup with a loop injection valve facilitates retrodialysis studies 2013 ·Journal of Pharmacological and Toxicological Methods ·K. V. Thrivikraman, Becky Kinkead, Karen Murray, Michael J. Owens	4
7	Trans , trans , trans -[PtIV(N3)2(OH)2(py)(NH3)]: A Light-Activated Antitumor Platinum Complex That Kills Human Cancer Cells by an Apoptosis-Independent Mechanism 2012 ·Molecular Cancer Therapeutics ·(unknown), Julie A. Woods, (unknown), Nicola J. Farrer, Luca Salassa, Kim S. Robinson, Virginia Appleyard, Karen Murray, Renate Grünert, Alastair M. Thompson, Peter J. Sadler, Patrick J. Bednarski	73
8	Phenformin as prophylaxis and therapy in breast cancer xenografts 2012 ·British Journal of Cancer ·M. Virginia C. L. Appleyard, Karen Murray, Philip J. Coates, Stephan Wullschleger, Susan E. Bray, Neil M. Kernohan, S. Fleming, Dario R. Alessi, Anne M. Thompson	89
9	Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters 2012 ·Cancer Chemotherapy and Pharmacology ·Timothy Smith, M. Virginia C. L. Appleyard, Sheila Sharp, Ian N. Fleming, Karen Murray, Alastair M. Thompson	17
10	Development of 18F-fluorinatable dendrons and their application to cancer cell targeting 2011 ·New Journal of Chemistry ·Laurent Trembleau, Michael Simpson, (unknown), Imma Escofet, (unknown), Karen Murray, Sheila Sharp, Alastair M. Thompson, Timothy Smith	25
11	Differential Contextual Responses of Normal Human Breast Epithelium to Ionizing Radiation in a Mouse Xenograft Model 2010 ·Cancer Research ·Philip J. Coates, (unknown), (unknown), Karen Murray, (unknown), (unknown), Douglas Brown, (unknown), Lee B. Jordan, Colin A. Purdie, Alastair J. Munro, Eric G. Wright, John Dewar, Alastair M. Thompson	19
12	Characterization, chemical optimization and anti-tumor activity of a tubulin poison identified by a p53-based phenotypic screen 2008 ·Cell Cycle ·Oliver Staples, Jonathan J. Hollick, Johanna Campbell, Maureen Higgins, Anna R. McCarthy, Virginia Appleyard, Karen Murray, Lee D. Baker, Alastair M. Thompson, Sébastien Ronseaux, Alexandra M. Z. Slawin, David P. Lane, Nicholas J. Westwood, Sonia Laı́n	12
13	Seliciclib (CYC202, R‐roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model 2008 ·International Journal of Cancer ·(unknown), Mary O’Neill, Karen Murray, F. Paulin, Susan E. Bray, Neil M. Kernohan, David A. Levison, David P. Lane, Alastair M. Thompson	43
14	Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator 2008 ·Cancer Cell ·Sonia Laı́n, Jonathan J. Hollick, Johanna Campbell, Oliver Staples, Maureen Higgins, Mustapha Aoubala, Anna R. McCarthy, Virginia Appleyard, Karen Murray, Lee D. Baker, Alastair M. Thompson, Joanne Mathers, Stephen J. Holland, Michael J. R. Stark, G. J. Pass, Julie A. Woods, David P. Lane, Nicholas J. Westwood	419
15	Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator 2007 ·Molecular Cancer Therapeutics ·Sonia Laı́n, Jonathan J. Hollick, Johanna Campbell, Oliver Staples, Maureen Higgins, Mustapha Aoubala, Anna R. McCarthy, Virginia Appleyard, Karen Murray, (unknown), Joanne Mathers, (unknown), (unknown), Julie A. Woods, David P. Lane, Nicholas J. Westwood	3
16	Thermographic assessment of tumor growth in mouse xenografts 2007 ·International Journal of Cancer ·Chengli Song, Virginia Appleyard, Karen Murray, Tim Frank, Wilson Sibbett, A. Cuschieri, Alastair M. Thompson	70
17	Determination of the phospholipid and sphingolipid content in the feces of uninfected BALB/c mice and those infected with Echinostoma caproni by high performance silica gel thin layer chromatography with densitometry 2007 ·Acta Chromatographica ·Karen Murray, Bernard Fried, J. Sherma	5
18	High Performance Thin Layer Chromatographic Analysis of Neutral Lipids in the Feces of BALB/c Mice Infected withEchinostoma caproni 2007 ·Journal of Liquid Chromatography & Related Technologies ·(unknown), Karen Murray, Bernard Fried, Joseph Sherma	11
19	Usnic acid: a non-genotoxic compound with anti-cancer properties 2005 ·Anti-Cancer Drugs ·(unknown), Mary O’Neill, Karen Murray, Nereide Stela Santos-Magalhães, Ana Maria dos Anjos Carneiro-Leão, Alastair M. Thompson, Virginia Appleyard	104
20	Activity of MDI-301, a novel synthetic retinoid, in xenografts 2004 ·Anti-Cancer Drugs ·Virginia Appleyard, (unknown), Karen Murray, Susan E. Bray, George Thomson, Neil M. Kernohan, James Varani, Jian Zhang, Alastair M. Thompson	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact